June 27, 2012 5:13 PM | 29 seconds read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Coronado Biosciences,Inc. (Nasdaq: CNDO), a biopharmaceutical company focused on the development ofnovel immunotherapy biologic agents for the treatment of autoimmune diseasesand cancer, announced today that it closed its previously announcedunderwritten public offering of 5,750,000 shares of its common stock at aprice to the public of $5.00 per share for gross proceeds to Coronado of $28.8million. The shares include 750,000 shares of common stock sold pursuant tothe over-allotment option granted by Coronado to the underwriters, whichoption was exercised in full. Coronado expects net proceeds of the offeringwill be approximately $26.5 million, after deducting underwriting commissionsand other offering expenses.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.